Phase 1 Small Lymphocytic Lymphoma (SLL) Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)+6 more

Nurix Therapeutics, Inc.572 enrolled62 locationsNCT05131022

Recruiting

Phase 1

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)+5 more

Nurix Therapeutics, Inc.248 enrolled16 locationsNCT04830137

Recruiting

Phase 1Phase 2

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Non-Hodgkin LymphomaMantle Cell LymphomaFollicular Lymphoma+5 more

CRISPR Therapeutics AG120 enrolled7 locationsNCT05643742